Document Detail


Cardiovascular effects of ghrelin antagonist in conscious rats.
MedLine Citation:
PMID:  19426765     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Ghrelin, a 28 aa growth-hormone-releasing peptide, has been shown to increase food intake and decrease arterial pressure in animals and in humans. Recently, a ghrelin antagonist (GhA), [d-Lys-3]-GHRP-6, was demonstrated to decrease food intake in mice, but its cardiovascular actions have not been described. In the present study, the effects of the GhA on cardiovascular parameters in conscious rats were investigated and the involvement of the sympathetic nervous system evaluated. Mean arterial pressure (MAP) and heart rate (HR) measurements were assessed by radiotelemetry. GhA was administered in doses of 2, 4 and 6 mg/kg subcutaneously (s.c.). MAP as well as HR was dose-dependently elevated after sc application of GhA. Sympathetic blockade of alpha-adrenoreceptors with phentolamine (3 mg/kg, s.c.) and simultaneous antagonism of beta(1)-adrenoreceptors with atenolol (10 mg/kg, s.c.) abolished the increase in MAP and HR induced by GhA (4 mg/kg, s.c.). Administration of phentolamine alone inhibited the increase of MAP, but not HR; atenolol alone abolished the elevation of both MAP and HR evoked by GhA. These results suggest that the peripheral injection of ghrelin antagonist increases arterial pressure and heart rate, at least in part, through the activation of the sympathetic nervous system. Therefore, the use of the ghrelin antagonist system as a therapeutic target for reduction in food intake might lead to serious side effects like elevated blood pressure in humans mostly already having an elevated blood pressure as part of their metabolic syndrome.
Authors:
Maria A Vlasova; Kristiina Järvinen; Karl-Heinz Herzig
Related Documents :
6507655 - Responses of primate t1-t5 spinothalamic neurons to gallbladder distension.
501665 - Arterial blood pressure and heart rate changes during self-stimulation by dogs in the b...
23043965 - Efficacy of moxibustion for pre- or stage i hypertension: study protocol for a pilot ra...
8079055 - Adrenaline-responsive electromechanical dissociation.
23576155 - Effect of the effortful swallow and the mendelsohn maneuver on tongue pressure producti...
1432335 - Ageing and wave reflection.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2009-05-06
Journal Detail:
Title:  Regulatory peptides     Volume:  156     ISSN:  1873-1686     ISO Abbreviation:  Regul. Pept.     Publication Date:  2009 Aug 
Date Detail:
Created Date:  2009-06-29     Completed Date:  2009-09-18     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8100479     Medline TA:  Regul Pept     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  72-6     Citation Subset:  IM    
Affiliation:
Department of Pharmaceutics, University of Kuopio, Kuopio, Finland. maria.vlasova@uku.fi
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adrenergic alpha-Antagonists / pharmacology
Animals
Atenolol / pharmacology
Blood Pressure / drug effects
Cardiovascular System / drug effects*
Consciousness*
Ghrelin / antagonists & inhibitors*
Heart Rate / drug effects
Male
Oligopeptides / pharmacology*
Phentolamine / pharmacology
Rats
Rats, Wistar
Receptors, Adrenergic, alpha / metabolism
Receptors, Adrenergic, beta-1 / antagonists & inhibitors
Sympathetic Nervous System / drug effects
Chemical
Reg. No./Substance:
0/Adrenergic alpha-Antagonists; 0/GHRP-6, Lys(3)-; 0/Ghrelin; 0/Oligopeptides; 0/Receptors, Adrenergic, alpha; 0/Receptors, Adrenergic, beta-1; 29122-68-7/Atenolol; 50-60-2/Phentolamine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A polyclonal antibody-based sandwich ELISA for the detection of bluetongue virus in cell culture and...
Next Document:  Identification of uropathogenic Escherichia coli surface proteins by shotgun proteomics.